President Biden and Sen. Bernie Sanders (I-Vt.) will hold a press conference at the White House to discuss recent inhaler price cuts by drug companies. As a result of their efforts, out-of-pocket costs for inhalers for many Americans will now be capped at $35. This is a significant step toward making essential medicines more accessible and affordable for all Americans.

Senator Sanders recently sent a letter to drug manufacturers urging them to review the prices of inhalers, as they were significantly higher in the United States compared to other countries such as the UK. The cost of one inhaler in the US was $645, 13 times more than what consumers in the UK were paying.

The press conference will be broadcast live and is expected to shed light on the importance of affordable healthcare and the government’s commitment to reducing the financial burden on patients. This is a positive development in ongoing efforts to make health care fairer for all Americans.

Health care professionals will also speak at the press conference, highlighting the impact that high prescription drug prices have on patient outcomes and their ability to access necessary treatments. They will also discuss the need for continued efforts to address this issue and ensure that all Americans have access to affordable and effective medication.

By Samantha Johnson

As a dedicated content writer at, I immerse myself in the art of storytelling through words. With a keen eye for detail and a passion for crafting engaging narratives, I strive to captivate our audience with each piece I create. Whether I'm covering breaking news, delving into feature articles, or exploring thought-provoking editorials, my goal remains constant: to inform, entertain, and inspire through the power of writing. Join me on this journalistic journey as we navigate through the ever-evolving media landscape together.

Leave a Reply